about
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancerMolecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment OutcomesEndoscopic molecular imaging of human bladder cancer using a CD47 antibody.Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agentsPrediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancerRadiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical applicationHomologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis.Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.Epigenetic therapy in urologic cancers: an update on clinical trials.Glycan-targeted drug delivery for intravesical therapy: in the footsteps of uropathogenic bacteria.The emerging role of extracellular vesicles as biomarkers for urogenital cancers.Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.Diagnostic Microdosing Approach to Study Gemcitabine Resistance.LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo.Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma.Enhanced efficacy of bleomycin in bladder cancer cells by photochemical internalization.A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatmentMiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: a New Zealand perspective.A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.Investigation of diffusion kurtosis imaging for discriminating tumors from inflammatory lesions after treatment for bladder cancer.Identification and bioinformatics analysis of miRNAs associated with human muscle invasive bladder cancer.BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.Photochemical internalization in bladder cancer - development of an orthotopic in vivo model.Bladder cancer in the EMPA-REG OUTCOME trial.Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder.Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.Paris Polyphylla-Derived Saponins Inhibit Growth of Bladder Cancer Cells by Inducing Mutant P53 Degradation While Up-Regulating CDKN1A Expression.High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer
P2860
Q24188295-E4233814-86A7-4DBD-A313-71E9A19C746EQ26765922-0C31B1FE-5F50-47E8-B91A-550F551ED7CEQ34445467-8EC209F8-A45F-4ADA-ADB9-E587B64DDD17Q34973750-4605BFDC-00C8-4992-9631-3D95D982E110Q34982947-D87EC992-FE0A-4373-B2A9-576D27941F2EQ35151119-42D12F38-6756-4343-A82B-C34723666664Q35201375-8EB7C455-22CB-4A6B-9E42-2F4FBC93E806Q35402431-B2467E9D-94F8-40E6-94A5-900B2EC045B2Q35752069-BD6FDF9C-0CDF-4C66-ABB6-4D514528D718Q35816480-0AF62D72-9F13-4098-9D39-802BCFCE7B4CQ36076728-0CCF58FC-6B9B-4EE8-8BA8-ED33F642866FQ36544451-25C3B23B-380A-4A84-92C3-7E2B20F6C33FQ37707110-D71936C0-2834-4413-AB5D-D0E4E2352733Q38226663-BC7DFE5A-BFD0-4438-AF34-9B680CBFAD01Q38268801-090E3E80-E487-4DB5-9C42-41B06503AFE5Q38620834-453A8C4A-D9D1-4986-A8B3-A36CD4A092BFQ38744400-393F1812-B650-488D-B182-993AC8DA7552Q38746137-A98D6706-CAB2-42AA-8DD9-184A3C0EF83AQ38761266-42B43D9A-F3E6-4667-88EF-EC9B429CE2C6Q38877184-30E67BD5-FAFE-4861-9D16-07F0AA1874D1Q38968160-05B3D375-741E-40B3-A012-31876F0FCDCCQ39121383-58862C06-44BC-4345-94D4-D8FFE9267B0DQ40625331-058764CB-8459-4A16-95C1-03C91A527AB4Q40734375-6311015B-AEFA-4F8E-A4B6-89AF06B9C6C8Q46216442-C3F64DC9-7BB6-41C9-A476-808A7F489122Q47114935-FDE97801-7C6F-4A49-ADA3-238D96D23473Q47324699-D2CE7919-8B0A-4565-B317-D6AA481D58B5Q47679651-F0770BF4-7ED8-4A15-B34F-DF08F528FB4FQ48119603-537D3ACA-A096-4F69-B7D7-CFEFECEE97DEQ48642623-96B879FA-A42B-47AF-BF3F-22351CAD13BDQ50076021-27DCF810-C00E-4804-8DDB-40FB01F9FD1CQ52604939-6B5639B5-8EB6-4C1F-BDCF-6DEE951A8484Q52687755-2A6C9215-59AB-40BE-8A50-B6D3278955BBQ52716922-0ABE1AC8-57B8-4216-A57F-AC9D1172C25FQ58763910-A6700A85-D9A8-4EBD-BD05-A2A67FA79A5A
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Current perspectives in bladder cancer management
@ast
Current perspectives in bladder cancer management
@en
Current perspectives in bladder cancer management
@nl
type
label
Current perspectives in bladder cancer management
@ast
Current perspectives in bladder cancer management
@en
Current perspectives in bladder cancer management
@nl
prefLabel
Current perspectives in bladder cancer management
@ast
Current perspectives in bladder cancer management
@en
Current perspectives in bladder cancer management
@nl
P2860
P3181
P356
P1476
Current perspectives in bladder cancer management
@en
P2093
T. R. L. Griffiths
P2860
P304
P3181
P356
10.1111/IJCP.12075
P407
P577
2013-05-01T00:00:00Z